Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;57(4):829-838.
doi: 10.1038/s41588-025-02140-2. Epub 2025 Apr 7.

Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum

Collaborators, Affiliations

Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum

David S M Lee et al. Nat Genet. 2025 Apr.

Abstract

Heart failure is a complex trait, influenced by environmental and genetic factors, affecting over 30 million individuals worldwide. Here we report common-variant and rare-variant association studies of all-cause heart failure and examine how different classes of genetic variation impact its heritability. We identify 176 common-variant risk loci at genome-wide significance in 2,358,556 individuals and cluster these signals into five broad modules based on pleiotropic associations with anthropomorphic traits/obesity, blood pressure/renal function, atherosclerosis/lipids, immune activity and arrhythmias. In parallel, we uncover exome-wide significant associations for heart failure and rare predicted loss-of-function variants in TTN, MYBPC3, FLNC and BAG3 using exome sequencing of 376,334 individuals. We find that total burden heritability of rare coding variants is highly concentrated in a small set of Mendelian cardiomyopathy genes, while common-variant heritability is diffusely spread throughout the genome. Finally, we show that common-variant background modifies heart failure risk among carriers of rare pathogenic truncating variants in TTN. Together, these findings discern genetic links between dysregulated metabolism and heart failure and highlight a polygenic component to heart failure not captured by current clinical genetic testing.

PubMed Disclaimer

Conflict of interest statement

Competing interests: E.M.M. consults for Amgen, Avidity, AstraZeneca, Cytokinetics, Janssen, PepGen, Pfizer, Stealth BioTherapeutics and Tenaya Therapeutics and is a founder of Ikaika Therapeutics. S. M. Damrauer receives research support from RenalytixAI and Novo Nordisk. N.R. reports speaker honoraria from Zoll, consulting fees from Roche Diagnostics, American Regent, Bristol Myers Squibb, AstraZeneca, Idorsia and Novo Nordisk, and research grant to her institution from Bristol Myers Squibb. The other authors declare no competing interests.

Update of

References

    1. Ziaeian B & Fonarow GC Epidemiology and aetiology of heart failure. Nat. Rev. Cardiol 13, 368–378 (2016). - PMC - PubMed
    1. Shah S et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat. Commun 11, 163 (2020). - PMC - PubMed
    1. Levin MG et al. Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure. Nat. Commun 13, 6914 (2022). - PMC - PubMed
    1. Aragam KG et al. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nat. Genet 54, 1803–1815 (2022). - PMC - PubMed
    1. Mahajan A et al. Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat. Genet 54, 560–572 (2022). - PMC - PubMed

Grants and funding

LinkOut - more resources